December 4, 2006 proved to be a fateful day for Pfizer – the day when it announced that the highly touted cholesterol modifying drug, torcetrapib, was being dropped from development.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,